These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 18694909)
1. The expression of most UDP-glucuronosyltransferases (UGTs) is increased significantly during Caco-2 cell differentiation, whereas UGT1A6 is highly expressed also in undifferentiated cells. Siissalo S; Zhang H; Stilgenbauer E; Kaukonen AM; Hirvonen J; Finel M Drug Metab Dispos; 2008 Nov; 36(11):2331-6. PubMed ID: 18694909 [TBL] [Abstract][Full Text] [Related]
2. Effects of cell differentiation and assay conditions on the UDP-glucuronosyltransferase activity in Caco-2 cells. Zhang H; Tolonen A; Rousu T; Hirvonen J; Finel M Drug Metab Dispos; 2011 Mar; 39(3):456-64. PubMed ID: 21098645 [TBL] [Abstract][Full Text] [Related]
3. Expression of UDP-glucuronosyltransferase 1A6 isoform in Caco-2 cells stimulated with lipopolysaccharide. Panaro MA; Cavallo P; Acquafredda A; Cianciulli A; Calvello R; Mitolo V Innate Immun; 2010 Oct; 16(5):302-9. PubMed ID: 19710100 [TBL] [Abstract][Full Text] [Related]
5. Quantitative analysis of UDP-glucuronosyltransferase (UGT) 1A and UGT2B expression levels in human livers. Izukawa T; Nakajima M; Fujiwara R; Yamanaka H; Fukami T; Takamiya M; Aoki Y; Ikushiro S; Sakaki T; Yokoi T Drug Metab Dispos; 2009 Aug; 37(8):1759-68. PubMed ID: 19439486 [TBL] [Abstract][Full Text] [Related]
6. Expression and inducibility of UDP-glucuronosyltransferase 1As in MCF-7 human breast carcinoma cells. Hanioka N; Iwabu H; Hanafusa H; Nakada S; Narimatsu S Basic Clin Pharmacol Toxicol; 2012 Mar; 110(3):253-8. PubMed ID: 21902811 [TBL] [Abstract][Full Text] [Related]
7. Prominent but reverse stereoselectivity in propranolol glucuronidation by human UDP-glucuronosyltransferases 1A9 and 1A10. Sten T; Qvisen S; Uutela P; Luukkanen L; Kostiainen R; Finel M Drug Metab Dispos; 2006 Sep; 34(9):1488-94. PubMed ID: 16763014 [TBL] [Abstract][Full Text] [Related]
8. Polymorphic expression of the UDP-glucuronosyltransferase UGT1A gene locus in human gastric epithelium. Strassburg CP; Nguyen N; Manns MP; Tukey RH Mol Pharmacol; 1998 Oct; 54(4):647-54. PubMed ID: 9765507 [TBL] [Abstract][Full Text] [Related]
9. Distribution and inducibility by 3-methylcholanthrene of family 1 UDP-glucuronosyltransferases in the rat gastrointestinal tract. Grams B; Harms A; Braun S; Strassburg CP; Manns MP; Obermayer-Straub P Arch Biochem Biophys; 2000 May; 377(2):255-65. PubMed ID: 10845702 [TBL] [Abstract][Full Text] [Related]
10. Human udp-glucuronosyltransferases: isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid. Uchaipichat V; Mackenzie PI; Guo XH; Gardner-Stephen D; Galetin A; Houston JB; Miners JO Drug Metab Dispos; 2004 Apr; 32(4):413-23. PubMed ID: 15039294 [TBL] [Abstract][Full Text] [Related]
11. Effect of oxidative stress on UDP-glucuronosyltransferases in rat astrocytes. Gradinaru D; Minn AL; Artur Y; Minn A; Heydel JM Toxicol Lett; 2012 Sep; 213(3):316-24. PubMed ID: 22846377 [TBL] [Abstract][Full Text] [Related]
12. Cloning and characterization of a canine UDP-glucuronosyltransferase. Soars MG; Smith DJ; Riley RJ; Burchell B Arch Biochem Biophys; 2001 Jul; 391(2):218-24. PubMed ID: 11437353 [TBL] [Abstract][Full Text] [Related]
13. Product inhibition of UDP-glucuronosyltransferase (UGT) enzymes by UDP obfuscates the inhibitory effects of UGT substrates. Fujiwara R; Nakajima M; Yamanaka H; Katoh M; Yokoi T Drug Metab Dispos; 2008 Feb; 36(2):361-7. PubMed ID: 17998297 [TBL] [Abstract][Full Text] [Related]
14. Tissue- and gender-specific mRNA expression of UDP-glucuronosyltransferases (UGTs) in mice. Buckley DB; Klaassen CD Drug Metab Dispos; 2007 Jan; 35(1):121-7. PubMed ID: 17050650 [TBL] [Abstract][Full Text] [Related]
15. How many and which amino acids are responsible for the large activity differences between the highly homologous UDP-glucuronosyltransferases (UGT) 1A9 and UGT1A10? Itäaho K; Laakkonen L; Finel M Drug Metab Dispos; 2010 Apr; 38(4):687-96. PubMed ID: 20089735 [TBL] [Abstract][Full Text] [Related]
16. Characterization of the UDP-glucuronosyltransferases involved in the glucuronidation of an antithrombotic thioxyloside in rat and humans. Pless D; Gouze JN; Senay C; Herber R; Leroy P; Barberousse V; Fournel-Gigleux S; Magdalou J Drug Metab Dispos; 1999 May; 27(5):588-95. PubMed ID: 10220487 [TBL] [Abstract][Full Text] [Related]
17. Highly variable pH effects on the interaction of diclofenac and indomethacin with human UDP-glucuronosyltransferases. Zhang H; Soikkeli A; Tolonen A; Rousu T; Hirvonen J; Finel M Toxicol In Vitro; 2012 Dec; 26(8):1286-93. PubMed ID: 22265884 [TBL] [Abstract][Full Text] [Related]
18. Human UDP-glucuronosyltransferase 1A5: identification, expression, and activity. Finel M; Li X; Gardner-Stephen D; Bratton S; Mackenzie PI; Radominska-Pandya A J Pharmacol Exp Ther; 2005 Dec; 315(3):1143-9. PubMed ID: 16120810 [TBL] [Abstract][Full Text] [Related]
19. Induction of human UDP glucuronosyltransferases (UGT1A6, UGT1A9, and UGT2B7) by t-butylhydroquinone and 2,3,7,8-tetrachlorodibenzo-p-dioxin in Caco-2 cells. Münzel PA; Schmohl S; Heel H; Kälberer K; Bock-Hennig BS; Bock KW Drug Metab Dispos; 1999 May; 27(5):569-73. PubMed ID: 10220484 [TBL] [Abstract][Full Text] [Related]